Heparanase in glomerular diseases (Q28303555)

Europe PubMed Central

title

Heparanase in glomerular diseases (English)

0 references

author name string

M J van den Hoven

1

0 references

A L Rops

2

0 references

I Vlodavsky

3

0 references

V Levidiotis

4

0 references

J H Berden

5

0 references

J van der Vlag

Order out of chaos: assembly of ligand binding sites in heparan sulfate

6

0 references

language of work or name

English

0 references

publication date

September 2007

0 references

published in

Kidney International

0 references

volume

72

0 references

issue

5

0 references

page(s)

543-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Heparan sulfate proteoglycans in glomerular inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: characterization and immunohistological application in human tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

No change in glomerular heparan sulfate structure in early human and experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Increased expression of heparanase in overt diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Identification of active-site residues of the pro-metastatic endoglycosidase heparanase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Substrate specificity of heparanases from human hepatoma and platelets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with different effects and the essential target disulfated trisaccharide sequence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Cellular uptake of mammalian heparanase precursor involves low density lipoprotein receptor-related proteins, mannose 6-phosphate receptors, and heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Site-directed mutagenesis, proteolytic cleavage, and activation of human proheparanase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Heparanase mediates cell adhesion independent of its enzymatic activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Increased expression of heparanase in puromycin aminonucleoside nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

ACE inhibition preserves heparan sulfate proteoglycans in the glomerular basement membrane of rats with established adriamycin nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

An ELISA method for the detection and quantification of human heparanase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Heparanase activity is dysregulated in children with steroid-sensitive nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Podocyte injury and targeting therapy: an update

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Structure and biological activity of heparinoid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002337

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5002337

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

2104851

1009747604

0 references

2104851

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference